文献速递肥胖与代谢综合征糖尿病

绝经过渡期血浆代谢物纵向变化及其与后续代谢综合征发病的关联

Longitudinal Study of Plasma Metabolites During Menopause and Their Associations With Later Onset of Metabolic Syndrome.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

本研究基于鹤冈代谢组学队列,纳入953名绝经前女性,平均随访5年,其中316人(33.2%)经历绝经。采用混合效应模型分析31种代谢物与绝经状态的关系,并用逻辑回归评估其与代谢综合征(MetS)发病的关联。

要点

  • 绝经过渡期与支链氨基酸、尿素循环及同型半胱氨酸代谢相关代谢物变化显著。
  • 谷氨酸水平升高与代谢综合征发病风险增加独立相关。
  • 谷氨酸、缬氨酸、亮氨酸和胱氨酸升高与高血糖发生相关。

核心结论

  • 绝经过渡期伴随带电代谢物的纵向变化,谷氨酸等特定代谢物可能参与增加MetS风险的代谢改变。

研究设计与样本

  • 基于鹤冈代谢组学队列的纵向研究,纳入至少参加一次随访调查的绝经前女性,平均随访5年。
  • 共纳入953名女性(年龄43.8±5.4岁),其中316人(33.2%)在随访期间(5.0±1.1年)达到绝经。
  • 采用混合效应模型分析31种代谢物与绝经状态的关联,并用逻辑回归(校正随访时间)评估其与MetS发病的关联。

主要发现

  • 基线无MetS的695名女性中,65人(9.4%)发生MetS。
  • 谷氨酸与MetS风险升高相关(OR 1.95,95%CI 1.49-2.57)。
  • 谷氨酸、缬氨酸、亮氨酸和胱氨酸水平较高与高血糖发生显著相关。

临床怎么用

  • 对于绝经过渡期女性,可关注谷氨酸等代谢物水平,辅助评估MetS及高血糖风险。
  • 针对支链氨基酸和同型半胱氨酸代谢通路的干预可能有助于降低绝经相关代谢风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Previous metabolomics studies suggest potential associations between menopausal changes in lipids and an increased risk of metabolic syndrome (MetS). However, longitudinal data on other key metabolites, such as branched-chain amino acids (BCAAs) and homocysteine, remain limited, and most studies lack long-term follow-up across the menopause transition. OBJECTIVE: This study aimed to investigate longitudinal changes in circulating metabolites during menopause over a mean follow-up of 5 years and assess their associations with subsequent MetS development. METHODS: Premenopausal women from the Tsuruoka Metabolomics Cohort Study who participated in at least one follow-up survey were included. Menopausal status, data on MetS, and plasma metabolites profiled using capillary electrophoresis mass spectrometry were assessed at each visit. Thirty-one metabolites were examined for associations with menopausal status using mixed-effects models. The association of these menopause-related metabolites with MetS development was examined via logistic regression analysis adjusted for follow-up duration. RESULTS: Among 953 women (aged 43.8 ± 5.4 years), 316 (33.2%) reached menopause during follow-up (5.0 ± 1.1 years). Eighteen metabolites changed significantly with menopause, particularly those related to BCAA metabolism, urea cycle, and homocysteine metabolism. Of 695 women without MetS at baseline, 65 (9.4%) developed MetS. Glutamate (odds ratio [95% CI]: 1.95 [1.49-2.57]) was associated with higher MetS risk. Higher levels of glutamate, valine, leucine, and cystine were significantly associated with the development of hyperglycemia. CONCLUSION: Longitudinal changes in charged metabolites occur across the menopausal transition, with specific metabolites such as glutamate possibly contributing to the metabolic alterations underlying increased MetS risk.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Miyake A, Iida M, Harada S, et al. Longitudinal Study of Plasma Metabolites During Menopause and Their Associations With Later Onset of Metabolic Syndrome. J Clin Endocrinol Metab. 2026. PMID: 41389027. doi:10.1210/clinem/dgaf666

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。